New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 4, 2014
07:51 EDTMRMindray Medical price target lowered to $42 from $50 at Oppenheimer
Oppenheimer cut its price target on Mindray Medical after the company reported stronger than expected Q4 results but provided lower than expected FY14 net income guidance. The firm keeps an Outperform rating on the stock.
News For MR From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
June 24, 2015
08:07 EDTMRMindray Medical forms special committee to evaluate 'going private' proposal
Mindray Medical announced that its board has formed a special committee comprised of three independent directors of the company, Ronald Ede, Kern Lim and Qiyao Wu, to consider the previously announced non-binding proposal received by the company's board on June 4, 2015 from Li Xiting, its Executive Chairman of the Board, President and Co-Chief Executive Officer, Xu Hang, its Chairman of the Board, and Cheng Minghe, its Co-Chief Executive Officer and Chief Strategic Officer. The Special Committee has retained Lazard Asia Limited as its independent financial advisor and Shearman & Sterling as its U.S. legal counsel to assist it in its evaluation of the Proposed Transaction and any other alternative transaction.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use